Deans' stroke musings: Saebo Announces FDA Clearance of SaeboVR - World's First Virtual ADL Rehabilitation System

Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Sunday, July 16, 2017

Saebo Announces FDA Clearance of SaeboVR - World's First Virtual ADL Rehabilitation System

My doctor pooh-poohed the idea of Saebo-Flex when I brought an article about it to him. I don't think he even knew about it at the time. That there showed his incompetence along with never telling me I had a stroke, just a CVA with no explanation. No clue what this is like, you'll have to google it yourself, your doctor will never mention it.
http://www.prnewswire.com/news-releases/saebo-announces-fda-clearance-of-saebovr---worlds-first-virtual-adl-rehabilitation-system-300486524.html?tc=eml_cleartime

News provided by

Saebo, Inc.

Jul 12, 2017, 08:11 ET

CHARLOTTE, N.C., July 12, 2017 /PRNewswire/ -- Saebo, Inc. announced on Wednesday that the U.S. Food and Drug Administration (FDA) has cleared SaeboVR, a virtual ADL (activities of daily living) rehabilitation system designed to engage neurological clients in both physical and cognitive challenges involving simulated functional tasks. This first-of-its-kind software system is grounded in National Institutes of Health (NIH)-sponsored research demonstrating the efficacy of virtual ADL practice for upper extremity rehabilitation.

SaeboVR's ADL-focused virtual world provides clients with real-life challenges. Users will incorporate their impaired upper limb to perform simulated self-care tasks that involve picking up, transferring and manipulating virtual objects. The proprietary platform recreates real, everyday life experiences including, but not limited to, grocery shopping, making breakfast, taking care of a pet, or planting a virtual garden. In addition to interacting with meaningful self-care tasks, SaeboVR uses a virtual assistant that appears on the screen to educate and facilitate performance by providing real-time feedback. As an added benefit, SaeboVR can be customized to challenge endurance, speed, range of motion, coordination, timing, and cognitive demand, thereby ensuring maximum success. After each session, SaeboVR displays graphical reports for easy viewing.
"As an occupational therapist working with individuals with neurological diagnoses, I want to provide realistic and meaningful activities that also offer many repetitions of movements to promote neuroplasticity," stated Allison Ellington, OTD, OTR/L. "SaeboVR is a motivating, engaging, and occupation-based product that allows for customizable and safe practice of activities that are meaningful to clients. Individuals who have used this system tell me they notice improvements in how they are able to use their impaired arm more functionally, which is so important."
This great excitement for SaeboVR is fueled by years of clinical research, as well. "Barron Associates, Inc. is excited to partner with Saebo in making virtual ADL practice a reality for patients and therapists," said Richard Adams, Ph.D. "The release of SaeboVR culminates five years of NIH-sponsored R&D and successful clinical trials that have provided a solid body of evidence for the efficacy of simulated ADLs in improving upper extremity motor function in individuals with acquired brain injury."
Saebo's Co-Founder, Henry Hoffman, notes that the SaeboVR is opening new opportunities for clinicians and patients alike. "As the world's only provider of a virtual reality system solely focused on simulated self-care tasks, SaeboVR opens new possibilities for clinicians and patients," he noted. "Prior to this break-through technology, motion capture programs were primarily focused on games rather than real-life functional tasks. Although computer-based exercises can be beneficial, often times, therapists report that games are not always appropriate for a certain patient population or lack significance to maintain a client's motivation and engagement. Thankfully, SaeboVR fills the void by not only being meaningful and relevant, but truly functional and appropriate for all ages."